GTC
ATYR

Ghost Tree Capital’s aTyr Pharma ATYR Stock Holding History

Ghost Tree Capital’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.41M Hold
800,000
– – 0.43% 51
2024
Q2 		$1.25M Buy
800,000
+200,000
+33% +$348K 0.39% 50
2024
Q1 		$1.17M Buy
+600,000
New +$1.05M 0.32% 66

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ghost Tree Capital's ATYR Position: Q3 2024 in Review

Ghost Tree Capital held its aTyr Pharma (ATYR) position steady in Q3 2024 at 800,000 shares worth $1.41M. The position accounts for 0.43% of the portfolio, ranked #51.

Ghost Tree Capital first reported a position in ATYR in Q1 2024 and has held it in 3 quarters since. 56 funds tracked by Wall St. Rank hold ATYR as of Q3 2024.

  • Ghost Tree Capital held 800,000 shares of aTyr Pharma worth $1.41M as of Q3 2024.
  • Ghost Tree Capital left its aTyr Pharma share count unchanged in Q3 2024.
  • aTyr Pharma made up 0.43% of Ghost Tree Capital's portfolio in Q3 2024, its #51 holding.
  • Ghost Tree Capital first reported a position in aTyr Pharma in Q1 2024 and has held it in 3 quarters since.
  • 56 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.